Final-Program-ATS-2023-AP.vp

WEDNESDAY • MAY 24

321

Chairing: C. Leon Astudillo, MD, Gainesville, FL

1016 A Real-World Study Assessing the Medical Cost Burden of Chronic Obstructive Pulmonary Disease (COPD) in the United States From 2016-2019 and Projections Through 2029: Analysis of Medical Expenditure Panel Survey (MEPS) Data/ D.M. Mannino, Lexington, KY 1017 Trends in Prevalence of Chronic Obstructive Pulmonary Disease in Immigrants to Ontario, Canada, 2002-2019/ J. Sugarman, Toronto, Canada 1018 Gold 1 Is a Highly Transitory Disease Stage in COPD: A Multistate Transition Modelling Analysis of the COPDGene Cohort/ L.M. Sánchez Romero, Washington, DC 1019 Investigating the Impact of Using Definitions of Exacerbation of COPD of Varying Validity on Study Findings in Routinely Collected Electronic Healthcare Records/ H. Whittaker, London, United Kingdom 1020 Disease Burden and Quality-of-Life (QoL) for Chronic Obstructive Pulmonary Disease (COPD) in the US - Evidence From the Medical Expenditure Panel Survey (MEPS) From 2016-2019/ M.H. Roberts, Albuquerque, NM 1021 Effects of Capsaicin on Permeability and Ciliary Function of Bronchial Epithelial Cells of Patients With Chronic Obstructive Pulmonary Disease (COPD)/ H. Bayram, Istanbul, Turkey 1022 The Association Between Inhaled Corticosteroid Therapy and Future Cardiovascular Events in People With Chronic Obstructive Pulmonary Disease (COPD)/ A.E. Ioannides, London, United Kingdom 1023 The Relationship Between Cardiac Troponin in Hospitalised Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients With Major Adverse Cardiac Events (MACE) and COPD Readmissions/ C. Kallis, London, United Kingdom 1024 Excess Incidence of Coronary Heart Disease Mortality Attributable to Lower Lung Function/ S.P. Bhatt, Birmingham, AL

J.B. Taylor, MD, MSCR, ATSF, Pittsburgh, PA J.M. Gaffin, MD, Boston, MA 901 Factors Associated With Functional Status Decline in Mechanically Ventilated PICU Bronchiolitis Patients Six Months Post-discharge/ M. Fischer, Cleveland, OH 902 Epidemiology of Complications Among Hospitalized Children With Hereditary Hemorrhagic Telangiectasia: A Kids’ Inpatient Database Study/ P.-Y. Tsou, Boston, MA 903 Functional Status at Waitlist Registration Is Associated With Probability of Lung Transplant in Pediatrics/ A. Himebauch, Philadelphia, PA 904 Determinants of Acceptance of COVID-19 Vaccine in Children: Does Pediatrician’s Opinion Matter?/ P. Mondal, Hershey, PA 905 COVID-19 Government Mandated Public Health Measures Associated With Increased Mask Use in Children/ L. Hahn, Edmonton, Canada 906 Pediatric Patients Diagnosed as Overweight or Obese Are More Likely to Be Diagnosed With Dyspnea/ L.L. Sandy, Dallas, TX 907 How Do Children and Adolescents Communicate the Experience of Dyspnea?/ J.W. Holm, Minneapolis, MN 908 Evaluating Dyspnea in Adolescents and Young Adults Using a Combined Isaac Questionnaire and Dalhousie Pictorial Scale Survey/ G. Alvernaz, Minneapolis, MN 909 Understanding the Experiences of Caregivers of Children With Spinal Muscular Atrophy in the Era of Disease-modifying Therapies/ L. Xiao, Toronto, Canada 910 Improving Resident Knowledge and Comfort With Screening and Counseling of Adolescent Vaping/ E. Sandler, Baltimore, MD 911 Developing an Entrustable Professional Activities-based Pediatric Pulmonology Fellowship Program/ A. Singh, Kansas City, MO 912 Implementing Kern’s Model to Define Strategies on Improving Fellow Recruitment and Quality of a Small Pediatric Pulmonology Fellowship Program/ A. Singh, Kansas City, MO 913 Medical-scholastic Partnership for Youth Understanding of the Concerns Over Electronic Cigarette Information: A Community Engagement Project/ G. Holder, Baltimore, MD 914 Participant Perspectives on the Implementation of a School-Linked Text Message Intervention to Improve Pediatric Asthma Medication Adherence/ M. Trivedi, Worcester, MA 915 Creation of a Tracheostomy Emergency and Airway Management Card/ J. White, Milwaukee, WI

CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

D27

IMPROVING PEDIATRIC PULMONOLOGY CARE: BEHAVIORAL AND HEALTH SERVICES RESEARCH

8:00 a.m. - 10:00 a.m.

Marriott Marquis Washington Marquis Ballroom, Salons 3-4 (Level M2)

Poster Viewing

8:00-8:45 8:45-10:00

Discussion

ATS 2023 • Washington, DC